Compounds > 2-(4-morpholinoanilino)-6-cyclohexylaminopurine
Page last updated: 2024-09-05

2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Myeloproliferative Disorders

2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with Myeloproliferative Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alves-Paiva, RM; Carlos, JAEG; Costa-Lotufo, LV; Hamerschlak, N; Lima, K; Machado-Neto, JA; Souza Santos, FP; Traina, F; Vicari, HP1

Other Studies

1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Myeloproliferative Disorders

ArticleYear
Reversine exhibits antineoplastic activity in JAK2
    Scientific reports, 2019, 07-09, Volume: 9, Issue:1

    Topics: Apoptosis; Aurora Kinase A; Aurora Kinase B; Biomarkers, Tumor; Cell Cycle; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Morpholines; Mutation; Myeloproliferative Disorders; Protein Kinase Inhibitors; Purines; Tumor Cells, Cultured

2019